Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Traumatic Brain Injury (TBI) Feasibility Study to Determine Possible Prognostic Indicators as Provided by the EPIC ClearView™

NCT02471625 is registered in ClinicalTrials.gov with Epic Research & Diagnostics, Inc. as lead sponsor.

NCT NCT02471625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02471625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Traumatic Brain Injury (TBI) Feasibility Study to Determine Possible Prognostic Indicators as Provided by the EPIC ClearView™
Lead sponsor
Epic Research & Diagnostics, Inc.
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2015
Completion date
Not reported
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

controls, traumatic brain injury